Market Research Logo

United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

United States Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Summary

GlobalData’s new report, United States Diabetes Care Devices Market Outlook to 2022, provides key market data on the United States Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for Diabetes Care Devices market.
  • Global corporate-level profiles of key companies operating within the United States Diabetes Care Devices market.
  • Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Diabetes Care Devices Market, United States
3.1 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2022
3.2 Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015
3.3 Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015
3.4 Diabetes Care Devices Market, United States, Revenue ($m), 2008-2015
3.5 Diabetes Care Devices Market, United States, Revenue ($m), 2015-2022
3.6 Diabetes Care Devices Market, United States, Volume (Units), 2008-2022
3.7 Diabetes Care Devices Market, United States, Volume (Units), 2008-2015
3.8 Diabetes Care Devices Market, United States, Volume (Units), 2015-2022
3.9 Diabetes Care Devices Market, United States, Company Share by Revenue ($m), 2015
4 Glucose Monitoring Market, United States
4.1 Glucose Monitoring Market, United States, Revenue Mix ($m), 2015
4.2 Glucose Monitoring Market, United States, Segment Contribution (%), 2015
4.3 Glucose Monitoring Market, United States, Revenue ($m), 2008-2015
4.4 Glucose Monitoring Market, United States, Revenue ($m), 2015-2022
4.5 Glucose Monitoring Market, United States, Volume (Units), 2008-2015
4.6 Glucose Monitoring Market, United States, Volume (Units), 2015-2022
4.7 Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), 2014-2015
4.8 Glucose Monitoring Market, United States, Company Share by Revenue ($m), 2015
5 Insulin Delivery Market, United States
5.1 Insulin Delivery Market, United States, Revenue Mix ($m), 2015
5.2 Insulin Delivery Market, United States, Segment Contribution (%), 2015
5.3 Insulin Delivery Market, United States, Revenue ($m), 2008-2015
5.4 Insulin Delivery Market, United States, Revenue ($m), 2015-2022
5.5 Insulin Delivery Market, United States, Volume (Units), 2008-2015
5.6 Insulin Delivery Market, United States, Volume (Units), 2015-2022
5.7 Insulin Delivery Market, United States, Distribution Share by Revenue ($m), 2014-2015
5.8 Insulin Delivery Market, United States, Company Share by Revenue ($m), 2015
6 Overview of Key Companies in United States, Diabetes Care Devices Market
6.1 Medtronic plc
6.2 Eli Lilly and Company
6.3 LifeScan Inc
6.4 Becton Dickinson and Co
6.5 Bayer HealthCare AG
6.6 Novo Nordisk A/S
6.7 Abbott Laboratories
6.8 Insulet Corp
6.9 DexCom Inc
6.10 F. Hoffmann-La Roche Ltd
6.11 Sanofi
6.12 Trividia Health Inc
7 Diabetes Care Devices Market Pipeline Products
8 Financial Deals Landscape
8.1 Acquisition
8.2 Debt Offerings
8.3 Equity Offerings
8.4 Partnerships
8.5 Private Equity
8.6 Venture Financing
9 Recent Developments
9.1 Corporate Communications
9.2 Financial Announcements
9.3 Government and Public Interest
9.4 Legal And Regulatory
9.5 Other Significant Developments
9.6 Product News
9.7 Strategy And Business Planning
10 Appendix
10.1 Research Methodology
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer
1.1 List of Tables
Table 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022
Table 2: Diabetes Care Devices Market, United States, Category Contribution by Revenue ($m), 2015
Table 3: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 5: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022
Table 6: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015
Table 7: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022
Table 8: Diabetes Care Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2015
Table 9: Glucose Monitoring Market, United States, Segment Contribution (%), 2015
Table 10: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 11: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 12: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 13: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 14: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015
Table 15: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022
Table 16: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015
Table 17: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022
Table 18: Glucose Monitoring Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 19: Glucose Monitoring Market, United States, Company Share by Revenue ($m), USD Constant, 2015
Table 20: Insulin Delivery Market, United States, Segment Contribution (%), 2015
Table 21: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 22: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 23: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 24: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 27: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015
Table 28: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022
Table 29: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015
Table 30: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015
Table 31: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022
Table 32: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022
Table 33: Insulin Delivery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 34: Insulin Delivery Market, United States, Company Share by Revenue ($m), USD Constant, 2015
Table 35: Diabetes Care Devices Market Pipeline Products
Table 36: BioTelemetry Acquires Telcare Medical Supply and Associated Assets
Table 37: CRF Health Acquires Entra Health Systems
Table 38: Abbott Labs to Acquire Alere
Table 39: Liberty Medical Acquires Neighborhood Diabetes from Insulet for USD5 Million
Table 40: MannKind May Sell Itself
Table 41: Teleflex Acquires Nostix
Table 42: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million
Table 43: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million
Table 44: Abbott Labs Prices Public Offering of 2.35% Notes due 2019 for USD2.9 Billion
Table 45: Abbott Labs Prices Public Offering of 2.9% Notes due 2021 for USD2.85 Billion
Table 46: Abbott Labs Prices Public Offering of 3.4% Notes due 2023 for USD1.5 Billion
Table 47: Abbott Labs Prices Public Offering of 3.75% Notes due 2026 for USD3 Billion
Table 48: Abbott Labs Prices Public Offering of 4.75% Notes due 2036 for USD1.7 Billion
Table 49: Abbott Labs Prices Public Offering of 4.9% Notes due 2046 for USD3.3 Billion
Table 50: Pfizer Raises USD1 Billion in Public Offering of 1.7% Notes Due 2019
Table 51: Pfizer Raises USD1 Billion in Public Offering of 2.2% Notes Due 2021
Table 52: Pfizer Raises USD1.8 Billion in Public Offering of 3% Notes Due 2026
Table 53: Pfizer Raises USD1 Billion in Public Offering of 4% Notes Due 2036
Table 54: Pfizer Raises USD1.3 Billion in Public Offering of 4.125% Notes Due 2046
Table 55: Thermo Fisher Scientific Raises USD1.2 Billion in Public Offering of Notes
Table 56: Thermo Fisher Scientific Raises USD670.8 Million in Public Offering of 1.375% Notes Due 2028
Table 57: Thermo Fisher Scientific Raises USD1.12 Billion in Public Offering of 1.375% Notes Due 2028
Table 58: Insulet Raises Private Placement of Senior Notes for USD300 Million
Table 59: Pfizer Raises USD1.25 Billion in Public Offering of 1.2% Notes Due 2018
Table 60: Pfizer Raises USD0.85 Billion in Public Offering of 1.45% Notes Due 2019
Table 61: Pfizer Raises USD1.15 Billion in Public Offering of 1.95% Notes Due 2021
Table 62: Pfizer Raises USD1.25 Billion in Public Offering of 2.75% Notes Due 2026
Table 63: Pfizer Raises USD0.5 Billion in Public Offering of 4.4% Notes Due 2044
Table 64: Echo Therapeutics Raises USD3.4 Million in Second and Final Tranche of Private Placement of Notes and Warrants
Table 65: Echo Therapeutics Raises USD1.8 Million in First Tranche Private Placement of Notes and Warrants
Table 66: GI Dynamics to Raise USD1.2 Million in Private Placement of CDIs
Table 67: ConvaTec Raises USD1.8 Billion in IPO
Table 68: Mannkind Prices Shares Issue for USD50 Million
Table 69: Valeritas Raises USD25 Million in Private Placement of Shares
Table 70: Senseonics Raises USD45 Million in Public Offering of Shares
Table 71: PharmaCyte Biotech Raises USD1 Million in Private Placement of shares
Table 72: Defymed Enters into Agreement with Semma Therapeutics
Table 73: Becton, Dickinson Enters into Research Agreement with Juvenile Diabetes Research Foundation
Table 74: Thermo Fisher Scientific Enters into Agreement with Hamilton Storage Technologies
Table 75: WellDoc Enters into Agreement with LifeScan
Table 76: Sanofi and Verily Life Sciences Form Joint Venture
Table 77: JDRF Enters into Co-Development Agreement with Arecor
Table 78: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies
Table 79: Profil Institute for Clinical Research Enters into Agreement with mySugr
Table 80: Diasend Partners with Abbott Labs
Table 81: Medtronic and Qualcomm Life Enter into Co-Development Agreement
Table 82: InSpark Technologies Enters into Agreement with Atlanta Diabetes Associates and East Carolina Diabetes and Obesity Institute
Table 83: Metabolon Enters into Licensing Agreement with Synlab
Table 84: LifeScan Enters into Agreement with WellDoc
Table 85: Insulet Enters into Licensing Agreement with Mode AGC
Table 86: Senseonics Enters into Agreement with Diasend
Table 87: Insulet Enters into Co-Development Agreement with Eli Lilly
Table 88: Warburg Pincus to Invest in Hygiena
Table 89: Intuity Medical Raises USD40 Million in Series 3 Financing
Table 90: Bigfoot Biomedical Raises USD35.5 Million in Series A Financing
Table 91: Glooko Raises USD8 Million in Financing Round
Table 92: Dance Biopharm Raises USD0.625 Million in Venture Financing
Table 93: Eccrine Systems Raises USD4.56 Million in Venture Financing
Table 94: Common Sensing Raises USD1.6 Million in Financing Round
Table 95: Optiscan Biomedical Raises USD29.5 Million in Financing Round
Table 96: DexCom Raises USD7.2 Million in Venture Financing
Table 97: Livongo Health Raises USD44.5 Million in Series C Financing Round
Table 98: WellDoc Raises USD7.5 Million in Extended Series B Financing
Table 99: Epinex Diagnostics Raises USD0.1 Million in Venture Financing
Table 100: Bigfoot Biomedical Raises USD2.37 Million in Venture Financing
1.2 List of Figures
Figure 1: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, 2008-2022
Figure 2: Diabetes Care Devices Market, United States, Revenue Mix ($m), 2015
Figure 3: Diabetes Care Devices Market, United States, Category Contribution (%), 2015
Figure 4: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 5: Diabetes Care Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 6: Diabetes Care Devices Market, United States, Volume (Units), 2008-2022
Figure 7: Diabetes Care Devices Market, United States, Volume (Units), Historic, 2008-2015
Figure 8: Diabetes Care Devices Market, United States, Volume (Units), Forecast, 2015-2022
Figure 9: Diabetes Care Devices Market, United States, Company Share (%) 2015
Figure 10: Glucose Monitoring Market, United States, Revenue Mix ($m), 2015
Figure 11: Glucose Monitoring Market, United States, Segment Contribution (%), 2015
Figure 12: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 13: Glucose Monitoring Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 14: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 15: Blood Glucose Meters Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 16: Glucose Monitoring Market, United States, Volume (Units), Historic, 2008-2015
Figure 17: Glucose Monitoring Market, United States, Volume (Units), Forecast, 2015-2022
Figure 18: Blood Glucose Meters Market, United States, Volume (Units), Historic, 2008-2015
Figure 19: Blood Glucose Meters Market, United States, Volume (Units), Forecast, 2015-2022
Figure 20: Glucose Monitoring Market, United States, Company Share (%) 2015
Figure 21: Insulin Delivery Market, United States, Revenue Mix ($m), 2015
Figure 22: Insulin Delivery Market, United States, Segment Contribution (%), 2015
Figure 23: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 24: Insulin Delivery Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 25: Insulin Pens Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 26: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 27: Insulin Pens Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 28: Insulin Pumps Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 29: Insulin Delivery Market, United States, Volume (Units), Historic, 2008-2015
Figure 30: Insulin Delivery Market, United States, Volume (Units), Forecast, 2015-2022
Figure 31: Insulin Pens Market, United States, Volume (Units), Historic, 2008-2015
Figure 32: Insulin Pumps Market, United States, Volume (Units), Historic, 2008-2015
Figure 33: Insulin Pens Market, United States, Volume (Units), Forecast, 2015-2022
Figure 34: Insulin Pumps Market, United States, Volume (Units), Forecast, 2015-2022
Figure 35: Insulin Delivery Market, United States, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report